119 related articles for article (PubMed ID: 22830523)
21. Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.
Viola F; Mapelli C; Villani E; Tresca Carducci F; Vezzola D; Ratiglia R
Eye (Lond); 2010 Aug; 24(8):1344-51. PubMed ID: 20339389
[TBL] [Abstract][Full Text] [Related]
22. Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.
Klais CM; Eandi CM; Ober MD; Sorenson JA; Sadeghi SN; Freund KB; Spaide RF; Slakter JS; Yannuzzi LA
Retina; 2006 Sep; 26(7):773-9. PubMed ID: 16963850
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation.
Ghazi NG; Knape RM; Kirk TQ; Tiedeman JS; Conway BP
Retina; 2008 May; 28(5):689-95. PubMed ID: 18463511
[TBL] [Abstract][Full Text] [Related]
24. Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization.
Do DV; Bressler SB; Cassard SD; Gower EW; Tabandeh H; Jefferys JL; Bressler NM
Retina; 2014 Oct; 34(10):2063-71. PubMed ID: 24978428
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal anti-vascular endothelial growth factor for retinal angiomatous proliferation in treatment-naive eyes: long-term functional and anatomical results using a modified PrONTO-style regimen.
Gharbiya M; Parisi F; Cruciani F; Bozzoni-Pantaleoni F; Pranno F; Abdolrahimzadeh S
Retina; 2014 Feb; 34(2):298-305. PubMed ID: 23807188
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
Roller AB; Folk JC; Patel NM; Boldt HC; Russell SR; Abramoff MD; Mahajan VB
Retina; 2011 Oct; 31(9):1848-55. PubMed ID: 21610563
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous resolution of retinal angiomatous proliferation.
Giudice GL; de Belvis V; Piermarocchi S; Prosdocimo G
Retin Cases Brief Rep; 2009; 3(1):38-41. PubMed ID: 25390835
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal ranibizumab treatment of retinal angiomatous proliferation.
Kramann CA; Schöpfer K; Lorenz K; Zwiener I; Stoffelns BM; Pfeiffer N
Acta Ophthalmol; 2012 Aug; 90(5):487-91. PubMed ID: 20584002
[TBL] [Abstract][Full Text] [Related]
30. Retinal angiomatous proliferation: natural history and progression of visual loss.
Viola F; Massacesi A; Orzalesi N; Ratiglia R; Staurenghi G
Retina; 2009 Jun; 29(6):732-9. PubMed ID: 19516115
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.
Krieglstein TR; Kampik A; Ulbig M
Br J Ophthalmol; 2006 Nov; 90(11):1357-60. PubMed ID: 16885191
[TBL] [Abstract][Full Text] [Related]
32. The role of spectral-domain optical coherence tomography in the diagnosis of retinal angiomatous proliferation.
Petropoulos IK; Matter MA; Katsimpris JM; Desmangles PM
Klin Monbl Augenheilkd; 2010 Apr; 227(4):309-11. PubMed ID: 20408082
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation.
Meyerle CB; Freund KB; Iturralde D; Spaide RF; Sorenson JA; Slakter JS; Klancnik JM; Fisher YL; Cooney MJ; Yannuzzi LA
Retina; 2007; 27(4):451-7. PubMed ID: 17420697
[TBL] [Abstract][Full Text] [Related]
34. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
35. Multimodal imaging of early stage 1 type 3 neovascularization with simultaneous eye-tracked spectral-domain optical coherence tomography and high-speed real-time angiography.
Querques G; Souied EH; Freund KB
Retina; 2013 Oct; 33(9):1881-7. PubMed ID: 23644560
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study.
Rouvas AA; Papakostas TD; Vavvas D; Vergados I; Moschos MM; Kotsolis A; Ladas ID
Retina; 2009 Apr; 29(4):536-44. PubMed ID: 19190547
[TBL] [Abstract][Full Text] [Related]
37. Short-term effects of a single intravitreal bevacizumab injection on retinal vessel calibre.
Tatlipinar S; Dinç UA; Yenerel NM; Görgün E
Clin Exp Optom; 2012 Jan; 95(1):94-8. PubMed ID: 21954975
[TBL] [Abstract][Full Text] [Related]
38. Retinal angiomatous proliferation.
Tsai ASH; Cheung N; Gan ATL; Jaffe GJ; Sivaprasad S; Wong TY; Cheung CMG
Surv Ophthalmol; 2017; 62(4):462-492. PubMed ID: 28189495
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
[TBL] [Abstract][Full Text] [Related]
40. Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point.
Brown DM; Chen E; Mariani A; Major JC;
Ophthalmology; 2013 Feb; 120(2):349-54. PubMed ID: 23131717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
